Cargando…
In vivo Cisplatin Resistance Depending upon Canalicular Multispecific Organic Anion Transporter (cMOAT)
The in vitro sensitivities to cisplatin of AH66 and AH66F cells, a variant obtained from AH66 cells, were very similar, when assayed in a medium containing 5% fetal bovine serum (FBS), whereas in the in vivo experiments AH66F cells were sensitive and AH66 cells were highly resistant to cisplatin. In...
Autores principales: | Minamino, Tomoyoshi, Tamai, Mitsuo, Itoh, Yoshie, Tatsumi, Yasuaki, Nomura, Masaaki, Yokogawa, Koichi, Suzuki, Hiroshi, Sugiyama, Yuichi, Ohshima, Tohru, Miyamoto, Ken‐ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925990/ https://www.ncbi.nlm.nih.gov/pubmed/10595747 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00692.x |
Ejemplares similares
-
Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
por: Oguri, T., et al.
Publicado: (1998) -
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
por: Belinsky, M G, et al.
Publicado: (1999) -
Expression of MRP and cMOAT in Childhood Neuroblastomas and Malignant Liver Tumors and Its Relevance to Clinical Behavior
por: Matsunaga, Tadashi, et al.
Publicado: (1998) -
MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
por: Halon, Agnieszka, et al.
Publicado: (2012) -
Why moats matter: the Morningstar approach to stock investing
por: Brilliant, Heather, et al.
Publicado: (2014)